Adema GJ - Search Results

1

Regulation of MYCN expression in human neuroblastoma cells.

Jacobs JF, van Bokhoven H, van Leeuwen FN, Hulsbergen-van de Kaa CA, de Vries IJ, Adema GJ, Hoogerbrugge PM, de Brouwer AP. Jacobs JF, et al. Among authors: adema gj. BMC Cancer. 2009 Jul 18;9:239. doi: 10.1186/1471-2407-9-239. BMC Cancer. 2009. PMID: 19615087 Free PMC article.

2

The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes.

Vissers JL, De Vries IJ, Schreurs MW, Engelen LP, Oosterwijk E, Figdor CG, Adema GJ. Vissers JL, et al. Among authors: adema gj. Cancer Res. 1999 Nov 1;59(21):5554-9. Cancer Res. 1999. PMID: 10554034

3

[Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer].

Punt CJ, de Vries IJ, Mulders PF, Adema GJ, Figdor CG. Punt CJ, et al. Among authors: adema gj. Ned Tijdschr Geneeskd. 1999 Nov 27;143(48):2408-14. Ned Tijdschr Geneeskd. 1999. PMID: 10608974 Review. Dutch.

4

Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.

dos Santos NR, Torensma R, de Vries TJ, Schreurs MW, de Bruijn DR, Kater-Baats E, Ruiter DJ, Adema GJ, van Muijen GN, van Kessel AG. dos Santos NR, et al. Among authors: adema gj. Cancer Res. 2000 Mar 15;60(6):1654-62. Cancer Res. 2000. PMID: 10749136

5

Renal cell carcinoma-associated antigen G250 encodes a naturally processed epitope presented by human leukocyte antigen-DR molecules to CD4(+) T lymphocytes.

Vissers JL, De Vries IJ, Engelen LP, Scharenborg NM, Molkenboer J, Figdor CG, Oosterwijk E, Adema GJ. Vissers JL, et al. Among authors: adema gj. Int J Cancer. 2002 Aug 1;100(4):441-4. doi: 10.1002/ijc.10518. Int J Cancer. 2002. PMID: 12115527 Free article.

6

Phenotypical and functional characterization of clinical grade dendritic cells.

de Vries IJ, Eggert AA, Scharenborg NM, Vissers JL, Lesterhuis WJ, Boerman OC, Punt CJ, Adema GJ, Figdor CG. de Vries IJ, et al. Among authors: adema gj. J Immunother. 2002 Sep-Oct;25(5):429-38. doi: 10.1097/00002371-200209000-00007. J Immunother. 2002. PMID: 12218781

7

Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study.

Oosterwijk-Wakka JC, Tiemessen DM, Bleumer I, de Vries IJ, Jongmans W, Adema GJ, Debruyne FM, de Mulder PH, Oosterwijk E, Mulders PF. Oosterwijk-Wakka JC, et al. Among authors: adema gj. J Immunother. 2002 Nov-Dec;25(6):500-8. doi: 10.1097/00002371-200211000-00006. J Immunother. 2002. PMID: 12439347 Clinical Trial.

8

Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.

De Vries IJ, Krooshoop DJ, Scharenborg NM, Lesterhuis WJ, Diepstra JH, Van Muijen GN, Strijk SP, Ruers TJ, Boerman OC, Oyen WJ, Adema GJ, Punt CJ, Figdor CG. De Vries IJ, et al. Among authors: adema gj. Cancer Res. 2003 Jan 1;63(1):12-7. Cancer Res. 2003. PMID: 12517769

9

Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.

de Vries IJ, Lesterhuis WJ, Scharenborg NM, Engelen LP, Ruiter DJ, Gerritsen MJ, Croockewit S, Britten CM, Torensma R, Adema GJ, Figdor CG, Punt CJ. de Vries IJ, et al. Among authors: adema gj. Clin Cancer Res. 2003 Nov 1;9(14):5091-100. Clin Cancer Res. 2003. PMID: 14613986

10

Phenotypical and functional characterization of clinical-grade dendritic cells.

de Vries IJ, Adema GJ, Punt CJ, Figdor CG. de Vries IJ, et al. Among authors: adema gj. Methods Mol Med. 2005;109:113-26. doi: 10.1385/1-59259-862-5:113. Methods Mol Med. 2005. PMID: 15585917 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page